Shareholding disclosure

TVM V Life Science Ventures GmbH & CO. KG

Declared position

Threshold

Fell below threshold

Timeline

Published

24.03.2018

Transaction

21.03.2018

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI3L000B9

Beneficial owner

TVM V Life Science Ventures GmbH & CO. KG

Declared address

TVM V LIFE SCIENCE VENTURES GMBH & CO. KG, 80333 MUNICH

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

TVM V Life Science Ventures GmbH & CO. KG

Addex Therapeutics Ltd24.03.2018TAI3L000B9

Disclosure summary

TVM V Life Science Ventures GmbH & CO. KG disclosed a holding in Addex Therapeutics Ltd that fell below the publication threshold, published by SIX Exchange Regulation on 24.03.2018, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

TVM V Life Science Ventures GmbH & CO. KG disclosed a holding in Addex Therapeutics Ltd, published on 24.03.2018.

Publication date24.03.2018

Transaction date21.03.2018

Issuing companyAddex Therapeutics Ltd

Beneficial ownerTVM V Life Science Ventures GmbH & CO. KG

Declared addressTVM V LIFE SCIENCE VENTURES GMBH & CO. KG, 80333 MUNICH

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAI3L000B9

Source: SIX Exchange Regulation · Publication date: 24.03.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open